Quarterly ResultAug 5, 2026, 04:23 PM
Exelixis Q2 Net Income $212.05M, Revenue $628.69M
AI Summary
Exelixis reported strong financial results for the second quarter and first six months of 2026. Net income for Q2 2026 increased to $212.05 million on total revenues of $628.69 million, driven by growth in net product revenues, primarily from CABOMETYX. The company also saw a significant increase in net cash provided by operating activities and continued its share repurchase program.
Key Highlights
- Net income for Q2 2026 increased 14.7% to $212.05 million.
- Total revenues for Q2 2026 rose 10.6% to $628.69 million.
- Diluted EPS for Q2 2026 grew 26.2% to $0.82.
- Net cash provided by operating activities for six months increased 114.9% to $559.59 million.
- Payments for common stock repurchases totaled $753.33 million for the six months.
- CABOMETYX net product revenues were $570.65 million in Q2 2026.
- Recognized $7.8 million in revenues from Takeda commercial milestone.
Price Impact
More from EXEL